BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38564692)

  • 1. Development and Evaluation of a Multisource Approach to Extend Mortality Follow-Up for Older Adults With Advanced Cancer Enrolled in Randomized Trials.
    Lund JL; Cacciatore J; Tylock R; Su IH; Sharma S; Hinton SP; Smith S; Nowels MA; Chen X; Duberstein PR; Hanson LC; Mohile SG
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300183. PubMed ID: 38564692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer: A Secondary Analysis of a Cluster Randomized Clinical Trial.
    Loh KP; Seplaki CL; Sanapala C; Yousefi-Nooraie R; Lund JL; Epstein RM; Duberstein PR; Flannery M; Culakova E; Xu H; McHugh C; Klepin HD; Lin PJ; Watson E; Grossman VA; Liu JJ; Geer J; O'Rourke MA; Mustian K; Mohile SG
    JAMA Netw Open; 2022 Feb; 5(2):e220018. PubMed ID: 35179585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research Program.
    Mohile SG; Epstein RM; Hurria A; Heckler CE; Canin B; Culakova E; Duberstein P; Gilmore N; Xu H; Plumb S; Wells M; Lowenstein LM; Flannery MA; Janelsins M; Magnuson A; Loh KP; Kleckner AS; Mustian KM; Hopkins JO; Liu JJ; Geer J; Gorawara-Bhat R; Morrow GR; Dale W
    JAMA Oncol; 2020 Feb; 6(2):196-204. PubMed ID: 31697365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of the ability to probabilistically link clinical trial patients to administrative data and determine long-term outcomes.
    Hay AE; Pater JL; Corn E; Han L; Camacho X; O'Callaghan C; Chong N; Bell EN; Tu D; Earle CC
    Clin Trials; 2019 Feb; 16(1):14-17. PubMed ID: 30466310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between administrative data and clinical review for mortality in the randomized on/off bypass follow-up study (ROOBY-FS).
    Quin JA; Hattler B; Shroyer ALW; Kemp D; Almassi GH; Bakaeen FG; Carr BM; Bishawi M; Collins JF; Grover FL; Wagner TH;
    J Card Surg; 2017 Dec; 32(12):751-756. PubMed ID: 29239024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UK EndoVascular Aneurysm Repair (EVAR) randomised controlled trials: long-term follow-up and cost-effectiveness analysis.
    Patel R; Powell JT; Sweeting MJ; Epstein DM; Barrett JK; Greenhalgh RM
    Health Technol Assess; 2018 Jan; 22(5):1-132. PubMed ID: 29384470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticosteroids for people with alcoholic hepatitis.
    Pavlov CS; Varganova DL; Casazza G; Tsochatzis E; Nikolova D; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD001511. PubMed ID: 29096421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving a randomized clinical trial into an observational cohort.
    Goodman PJ; Hartline JA; Tangen CM; Crowley JJ; Minasian LM; Klein EA; Cook ED; Darke AK; Arnold KB; Anderson K; Yee M; Meyskens FL; Baker LH
    Clin Trials; 2013 Feb; 10(1):131-42. PubMed ID: 23064404
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.